期刊文献+

幽门螺杆菌napA-ctxB融合蛋白的基因克隆与表达 被引量:2

Cloning and expression of Helicobacter pylori napA-ctxB fusion protein
暂未订购
导出
摘要 目的克隆、表达幽门螺杆菌中性粒细胞激活蛋白napA与霍乱毒素B亚单位ctxB融合基因napA-ctxB(nctB),为制备预防H.pylori感染的疫苗奠定基础。方法用PCR方法扩增ctxB目的基因片段,克隆至pQE30-napA质粒的napA基因上游,构建含双基因的表达质粒pQE30-napA-ctxB(pQE30-nctB),经测序分析确认后转化E.coliDH5α,经IPTG诱导表达融合蛋白NCTB,融合蛋白NCTB经镍离子柱纯化。结果PCR扩增出807bp的目的基因片段nctB。工程菌pQE30-nctB-DH5α经IPTG诱导后,SDS-PAGE显示有新生的蛋白表达条带,Mr为30000,与预期的一致,约占菌体总蛋白的27%,重组蛋白用Ni2+-NTA树脂提纯,纯化后的蛋白质经SDS-PAGE分析可见单一条带,图象软件分析表明纯度可达94%以上。Westernblot显示重组蛋白质有良好的抗原性。结论构建含双基因的表达质粒pQE30-nctB成功,并在大肠杆菌DH5α中高效的表达。 Objective To construct the fusion gene of H. pylori neutrophil activating protein (napA) and cholera toxin subunit B (ctxB) and expressed it in E. coli DH5α. Methods The ctxB gene was amplified by PCR and cloned into plasmld pQE30-napA. The recombinant plasmid was identified by sequencing, and then transformed into E. coli DH5α. The transfonnant colony was induced with IPTG and the expressed protein was purified by Ni^2+ -NTA column chromatography. Expression of the fusion protein was analyzed by SDS-PAGE and Western blotting. Results The gene fragment at length of 807 bp was amplified and cloned into plasmid pQE30 successfully. SDS-PAGE showed a protein band with relative molecular weight of 30 000, which was consistent with the expectation. The expressed product contained about 27% of total somatic protein, and reached a purity of 94% after Ni^2+ -NTA column chromatograph. Western blot method showed good antigenicity of the recombinant protein. Conclusion The recombinant plasmid of neutrophil activating protein(napA) and cholera toxin subunit B (ctxB) is suecessfully construeted and the napA-ctxB gene is highly expressed in E. coli DH5α. The fusion protein could be used in development of Helicobacter pylori vaccine.
出处 《免疫学杂志》 CAS CSCD 北大核心 2007年第2期172-175,共4页 Immunological Journal
关键词 幽门螺杆菌 中性粒细胞激活蛋白 霍乱毒素B亚单位 融合基因 Helicobacter pytori Neutrophil activating protein Cholera toxin subunit B Fusion gene
  • 相关文献

参考文献9

  • 1吴亚男,邹全明,罗萍,郭刚,王晓勤.幽门螺杆菌UreB单克隆抗体的制备及尿素酶活性抑制能力的研究[J].免疫学杂志,2005,21(5):393-396. 被引量:6
  • 2Satin B, Del Giudice G, Della bianca V, et al. The Neutrophil-activating Protein(Hp-NAP) of Hp is a Protective Antigen and a major Virulence Factor [J]. Exp Med,2000, 191(9):1467-1476.
  • 3Namavar F, Sparrius M, Veerman Ec, et al. Neutrophil-activating protein mediates adhesion of Helicobacter pylori to sulfated carbohydrates on high-molecular-weight salivary mucin[J]. Infect Immun, 1998,66(2):444-447.
  • 4Kotloff KL, Sztein MB, Wasserma SS, et al. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection[J]. Infection Immun, 2001, 69(6):3581-3590.
  • 5Yamamoto M, McGhee JR, Hagiwara Y, et al. Genetically manipulated bacterial toxin as a new generation mucosal adjuvant[J]. Scand J Immunol, 2001, 53(3):211-217.
  • 6颜子颖 王海林.精编分子生物学实验指南[M].北京:科学出版社,1999.649-652.
  • 7Vyas SP, Sihorkar V. Exploring novel vaccines against Helicobacter pylori: protective and therapeutic immunization[J]. J Clin Pharm Ther, 1999, 24(4):259-265.
  • 8Micbetti P. Oral Immunization against Helicobacter pylori-a future concept[J]. J Gastroenterol, 1998,33(Suppl 10):66-68.
  • 9Dundon WG, Nishioka H, Polenghi A,et al. The neutrophilactivating protein of Helicobacter pylori[J]. Int J Med Microbiol,2002,291(6/7):545-550.

二级参考文献6

共引文献18

同被引文献19

  • 1周维英,吴超,石云,张卫军,邹全明.幽门螺杆菌双亚单位表位融合蛋白的构建、表达及鉴定[J].免疫学杂志,2007,23(2):121-125. 被引量:4
  • 2潘赛贻,黄健康,周洁娴,吴建民.杂交瘤技术方法的建立和融合条件的研究[J].湖南医科大学学报,1997,22(2):179-182. 被引量:6
  • 3Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries [J]. Aliment Phannacol, 1995, 9 (Suppl 2) : S33 - S39.
  • 4International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. IARC Monograph on the Evaluation of Carcinggenic Risks to Hmnan. Vol61, Lyon: IARC, 1994.
  • 5Evans DG, Evans DJ, Jr, l_ampert HC, et al. Restriction fragment length polymorphism in the adhesin gene HpaA of Helicobacter pylori[J]. Am J Gastroenterol, 1995, 90 (8) : 1282-1288.
  • 6Mine Y, Kovacs Nolan J. Chicken egg yolk antibodies as therapeutics in enteric infectious disease: a review [J]. J Med Food, 2002, 5 (3): 159-169
  • 7Akita EM, Nakai S. Preparationand purification of Fab' immunoreactive fragments from chicken egg immunoglobulin using pepsin and Aspergillus saitoi protease[ A]//Egg uses and processing technologies (ed. Sim JS &Nakai S), Wallingford, Canada: CAB International, 1994:228 - 240.
  • 8Peck B, Ortkamp M, Diehl KD, et al. Conservation, localization and expression of HopZ, a protein involved in adhe sion of Helicobacter pylori [ J ]. Nuclei Acids Res, 1999, 27 (16) :3 325 - 3 333.
  • 9Shin JH, Yang M, Nam SW, et al. Use of egg yolk-derived immunoglobulin as an alternative to antibiotic treatment for control of Helicobacter pylori infection [ J ]. Clin Diagn Lab lmmunol, 2002, 9 (5): 1 061- 1 066.
  • 10Evans DG, Karjalainen TK, Evans DJ, Jr, et al. Cloning nucleotide sequence, and expression of a gene encoding an adhesin subunit protein of Helicobacter pylori[J]. J Bacteriol, 1993, 175 (3) : 674- 683.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部